Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ribavirin in acute viral hepatitis.

G H Tilve1, K C Patel, V M Mogre

  • 1Department of Medicine, K. E. M. Hospital, Parel, Bombay, Maharashtra.

Journal of Postgraduate Medicine
|July 1, 1991
PubMed
Summary

Ribavirin therapy significantly improved symptoms and normalized blood parameters in patients with acute viral hepatitis (excluding hepatitis B). This antiviral medication was well-tolerated, offering a promising treatment option in India.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanotechnology strategies for enhancing productivity, sulphur use efficiency and soil fertility in groundnut-mustard cropping systems.

Scientific reports·2026
Same author

Combining ability, heterosis and performance of grain yield and content of Fe, Zn and protein in bread wheat under normal and late sowing conditions.

PeerJ·2023
Same author

Transfer of self-aligned spacer patterns for single-digit nanofabrication.

Nanotechnology·2015
Same author

Curdlan-like exopolysaccharide production by Cellulomonas flavigena UNP3 during growth on hydrocarbon substrates.

World journal of microbiology & biotechnology·2014
Same author

Incidence of post-operative endophthalmitis following 23-gauge transconjunctival sutureless vitrectomy in the United Kingdom: a survey.

Eye (London, England)·2011
Same author

PHA-rubber blends: synthesis, characterization and biodegradation.

Bioresource technology·2007

Area of Science:

  • Hepatology
  • Virology
  • Clinical Pharmacology

Background:

  • Acute viral hepatitis (AVH) is a significant public health concern, particularly in India, often characterized by epidemics.
  • Currently, effective antiviral treatments for AVH, excluding hepatitis B, are limited.

Purpose of the Study:

  • To evaluate the efficacy and safety of ribavirin in treating acute viral hepatitis (excluding hepatitis B).

Main Methods:

  • A double-blind clinical trial involving 64 patients with AVH (excluding hepatitis B).
  • Patients were randomly assigned to receive either ribavirin (200 mg four times daily) or a placebo.
  • Final analysis included 60 patients due to four lost to follow-up.

Main Results:

  • Ribavirin treatment led to rapid and significant improvement in clinical symptoms like nausea and vomiting, alongside appetite restoration.
  • Abnormal blood parameters showed a significant and rapid normalization trend in the ribavirin group compared to the placebo group.
  • Ribavirin was well-tolerated, with no reported side effects during the trial.

Conclusions:

  • Ribavirin demonstrates significant efficacy in managing acute viral hepatitis (excluding hepatitis B), improving both symptomatic and biochemical parameters.
  • The favorable safety profile and effectiveness of ribavirin make it a valuable therapeutic option for AVH in regions like India.

Related Experiment Videos